IP Library Patent Application 11974610
Patent Application
App. No. 11/974,610

Functional and hyperfunctional siRNA directed against Bcl-2

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/974,610
Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.

Claims (10)

1 . An siRNA molecule effective at silencing Bcl-2 expression, wherein said: molecule comprises a sense region and an antisense region, wherein said sense region and said antisense region together form a duplex region comprising 19-30 base pairs and said antisense region comprises a sequence that is the reverse complement of SEQ. ID NO. 302.

2 . The siRNA of claim 1 , wherein said antisense region and said sense region are each 19-25 nucleotides in length.

3 . The siRNA of claim 1 , wherein said antisense region and said sense region are each 19 nucleotides in length.

4 . The siRNA of claim 1 , wherein said antisense region is 100% complementary to a target Bcl-2 RNA.

5 . The siRNA molecule of claim 1 , wherein said siRNA molecule comprises at least one overhang region, wherein said overhang region comprises six or fewer nucleotides.

6 . The siRNA molecule of claim 1 wherein said siRNA molecule comprises no overhang regions.

7 . The siRNA molecule of claim 2 wherein said siRNA molecule comprises at least one overhang region, wherein said overhang region comprises six or fewer nucleotides.

8 . The siRNA molecule of claim 2 wherein said siRNA molecule comprises no overhang regions.

9 . The siRNA molecule of claim 3 wherein said siRNA molecule comprises at least one overhang region, wherein said overhang region comprises six or fewer nucleotides.

10 . The siRNA molecule of claim 3 wherein said siRNA molecule comprises no overhang regions.

Assignments (4)
CHANGE OF NAME Recorded Apr 30, 2014
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 032790/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2014
From: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
To: THERMO FISHER SCIENTIFIC INC.
Reel/Frame 032720/0846 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2010
From: KHVOROVA, ANASTASIA; REYNOLDS, ANGELA; LEAKE, DEVIN; MARSHALL, WILLIAM; READ, STEVEN; SCARINGE, STEPHEN
To: DHARMACON, INC.
Reel/Frame 023831/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2007
From: KHVOROVA, ANASTASIA; REYNOLDS, ANGELA; LEAKE, DEVIN; MARSHALL, WILLIAM; SCARINGE, STEPHEN
To: DHARMACON, INC.
Reel/Frame 020036/0914 →